Literature DB >> 28167086

Entrainment Mapping.

Saurabh Kumar1, Usha B Tedrow1, William G Stevenson2.   

Abstract

Mapping during ventricular tachycardia (VT) aims to elucidate mechanism, describe myocardial propagation, and identify the origin and critical regions of VT that can be targeted for ablation, most commonly with radiofrequency ablation. Most VTs in structural heart disease are due to macro-reentry in and around scar. A combination of mapping techniques, including mapping to identify the arrhythmia substrate, activation sequence mapping, pace-mapping, and entrainment mapping, may be used to identify putative ablation targets. This review describes the principles of entrainment mapping as it pertains to catheter ablation of scar-related VT. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catheter ablation; Concealed entrainment; Entrainment mapping; Fusion; Postinfarction; Resetting; Ventricular tachycardia

Mesh:

Year:  2017        PMID: 28167086     DOI: 10.1016/j.ccep.2016.10.004

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  2 in total

1.  Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.

Authors:  Stefano Pedretti; Sara Vargiu; Matteo Baroni; Santo Dellegrottaglie; Barbara Lanzarin; Alberto Roghi; Angela Milazzo; Giuseppina Quattrocchi; Maurizio Lunati; Patrizia Pedrotti
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

Review 2.  Mapping of ventricular tachycardia in patients with ischemic cardiomyopathy: Current approaches and future perspectives.

Authors:  Claudio Pandozi; Carlo Lavalle; Maurizio Russo; Marco Galeazzi; Sabina Ficili; Maurizio Malacrida; Carlos Centurion Aznaran; Furio Colivicchi
Journal:  Clin Cardiol       Date:  2019-08-14       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.